J Neurol Surg Rep 2015; 76(01): e156-e159
DOI: 10.1055/s-0035-1554930
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Plasmacytoma of the Clivus Presenting as Bilateral Sixth Nerve Palsy

Neil Kalwani*
1   Section of Otology and Laryngology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States
,
Aaron K. Remenschneider*
1   Section of Otology and Laryngology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States
,
William Faquin
2   Section of Pathology, Department of Otolaryngology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
,
Judith Ferry
3   Section of Pathology, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
,
Eric H. Holbrook
1   Section of Otology and Laryngology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States
› Author Affiliations
Further Information

Publication History

02 November 2014

12 March 2015

Publication Date:
26 June 2015 (online)

Abstract

Background and Importance Plasmacytomas are monoclonal proliferations of plasma cells that may arise within soft tissue or bone. The skull base is a rare site for plasmacytomas to occur, and few cases have been reported in the literature. When present in the skull base, plasmacytomas may result in cranial neuropathies and often progress to multiple myeloma more rapidly than other intracranial or skeletal plasmacytomas.

Clinical Presentation A 69-year-old man presented with a primary complaint of diplopia and an examination consistent with bilateral abducens nerve palsy. No other deficits were noted. Magnetic resonance imaging of the skull base demonstrated a large T1 isointense moderately enhancing lesion centered within the clivus. Endoscopic biopsy of the mass revealed sheets and aggregates of mature monoclonal plasma cells. The patient's initial systemic work-up revealed that this was a solitary lesion, and he was treated with radiation therapy to the skull base with a durable local effect at 18-month follow-up. Unfortunately he progressed to multiple myeloma with peripheral osteolytic lesions but has been stabilized on chemotherapeutics.

Conclusion The clivus is an unusual site for intracranial plasmacytomas, and enhancing lesions must be differentiated from chordoma. Characteristic findings on histopathology include an immunoglobulin light-chain restricted clonal proliferation of plasma cells. Treatment is most commonly radiotherapy with surgery reserved for biopsy and palliation. Clinicians should be aware of the increased risk of progression to multiple myeloma in skull base plasmacytomas.

* Authors contributed equally to this work.


 
  • References

  • 1 Cerase A, Tarantino A, Gozzetti A , et al. Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology 2008; 50 (8) 665-674
  • 2 Schwartz TH, Rhiew R, Isaacson SR, Orazi A, Bruce JN. Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study. Neurosurgery 2001; 49 (5) 1039-1044 ; discussion 1044–1045
  • 3 Wein RO, Popat SR, Doerr TD, Dutcher PO. Plasma cell tumors of the skull base: four case reports and literature review. Skull Base 2002; 12 (2) 77-86
  • 4 McKenna R, Kyle R, Kuehl W, Grogan T, Harris N, Coupland R. Plasma cell neoplasms. In: Swerdlow S, Campo E, Harris N, , et al, eds. WHO Classification Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC; 2008: 200-213
  • 5 Gagliardi F, Boari N, Mortini P. Solitary nonchordomatous lesions of the clival bone: differential diagnosis and current therapeutic strategies. Neurosurg Rev 2013; 36 (4) 513-522 ; discussion 522
  • 6 Gagliardi F, Losa M, Boari N , et al. Solitary clival plasmocytomas: misleading clinical and radiological features of a rare pathology with a specific biological behaviour. Acta Neurochir (Wien) 2013; 155 (10) 1849-1856
  • 7 Bindal AK, Bindal RK, van Loveren H, Sawaya R. Management of intracranial plasmacytoma. J Neurosurg 1995; 83 (2) 218-221
  • 8 Ustuner Z, Basaran M, Kiris T , et al. Skull base plasmacytoma in a patient with light chain myeloma. Skull Base 2003; 13 (3) 167-171
  • 9 Yamaguchi S, Terasaka S, Ando S, Shinohara T, Iwasaki Y. Neoadjuvant therapy in a patient with clival plasmacytoma associated with multiple myeloma: a case report. Surg Neurol 2008; 70 (4) 403-407
  • 10 Soutar R, Lucraft H, Jackson G , et al; Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 2004; 16 (6) 405-413
  • 11 Nofsinger YC, Mirza N, Rowan PT, Lanza D, Weinstein G. Head and neck manifestations of plasma cell neoplasms. Laryngoscope 1997; 107 (6) 741-746